Pro-Dex, Inc. Announces Fiscal 2027 First Quarter Results
Key Highlights
- ➤Net sales $20.6 million, up 11% year over year
- ➤Gross margin increased four percentage points to 33%
- ➤Operating income $3.5 million, up 13% year over year
- ➤Net income $3.0 million, or $0.92 diluted EPS, versus $4.7 million
- ➤Pro-Dex expects to ship Monogram validation units later this fiscal year
Expert Statements
Richard L. Van Kirk, President and Chief Executive Officer of Pro-Dex, Inc.
“We are pleased with our first quarter results and continued top line revenue growth.”
Richard L. Van Kirk, President and Chief Executive Officer of Pro-Dex, Inc.
“We are also pleased to be working with the Monogram and Zimmer Biomet teams and expect to ship validation units later this fiscal year.”
IRVINE, CA / ACCESS Newswire / October 29, 2026 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2027 first quarter ended September 30, 2026. The Company also filed its Quarterly Report on Form 10-Q for the first quarter of fiscal year 2027 with the Securities and Exchange Commission today.
Net sales for the three months ended September 30, 2026, increased $2.1 million, or 11%, to $20.6 million from $18.5 million for the three months ended September 30, 2025. The increase is driven primarily by a $3.3 million increase in medical device revenue, inclusive of rebates, of which $1.8 million relates to the next-generation handpiece we sell to our largest customer, offset by a $1.7 million decrease in repairs of the legacy handpiece we sell to that customer, coupled with an increase in revenue of $511,000 generated by the Company's newly acquired subsidiary, Advanced Precision Machining, LLC ("APM"), exclusive of inter-company sales in the amount of $814,000 which are eliminated in consolidation.
Get started
Create a free account to read the full story.